Benoxinate hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for benoxinate hydrochloride and what is the scope of patent protection?
Benoxinate hydrochloride
is the generic ingredient in three branded drugs marketed by Sola Barnes Hind, Altaire Pharms Inc, and Bausch Lomb Ireland, and is included in three NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for benoxinate hydrochloride.
Summary for benoxinate hydrochloride
| US Patents: | 3 |
| Tradenames: | 3 |
| Applicants: | 3 |
| NDAs: | 3 |
| Drug Master File Entries: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 84 |
| Clinical Trials: | 4 |
| Patent Applications: | 709 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | benoxinate hydrochloride at DailyMed |
Recent Clinical Trials for benoxinate hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Alexandria University | N/A |
| Zagazig University | Phase 3 |
| Cairo University | Phase 3 |
